Aenova Sterile Fill Finish & PFS manufacturing

Aenova Sterile Fill Finish & PFS manufacturing
Product Description

The Aenova Group is a premier solution partner for sterile dosage forms with 3 FDA approved facilities offering high quality injectables for human health and animal health products.

Our Sterile services include specialized capabilities for:

Beta-lactams (penicillins, cephalosporins)Intra-mammary syringes for animal health productsCytotoxicsFill & finish of biologics

Aenova

  • US
  • 2017
    On CPHI since
Specifications

Aenova

  • US
  • 2017
    On CPHI since

More Products from Aenova (2)

  • Aenova CDMO Manufacturing Services INtro

    Product Aenova CDMO Manufacturing Services INtro

    With 15 production sites in Europe and the USA, the Aenova Group offers a broad range of dosage forms for Pharmaceutical and Consumer Health products. Our sites are equipped with the latest production technologies and have proven expertise to support your product needs with the highest quality and reliabil...
  • Aenova Softgel Manufacturing Services

    Product Aenova Softgel Manufacturing Services

    Aenova has more than 35 years of experience in the formulation and analytical development and production of soft gelatin capsules.

    Our production facilities are equipped with state-of-the-art equipment to process any formulation and any capsule design, color and size.

    With development...

Aenova resources (2)

  • News Aenova expands portfolio with innovative technologies

    The development of new drug products for a wide range of therapeutic areas is a rapidly growing market. Therefore, a smart innovation strategy is essential for contract developers and manufacturers. Aenova is expanding its development and production portfolio, particularly in the area of bioavailability of active pharmaceutical ingredients.

  • Brochure Aenova CDMO Services

    Aenova is a leading contract development and manufacturing organization (CDMO) for the pharmaceutical and healthcare industry worldwide. The range of services covers the entire value chain of development and production of all common dosage forms (solid, semi-solid and liquid, sterile and non-sterile; high potency and low dosage) and product groups in drugs and food supplements for human and animal health.  Aenova offers its customers full service, ranging from product development to the purchase of raw materials, production, analytics, market release. Aenova develops, produces and packages at 15 locations in Europe and USA. Around 4,500 employees contribute to the success of Aenova. www.aenova-group.com